Topics:

Probable New Herpesvirus Linked to Kaposi's Sarcoma

Probable New Herpesvirus Linked to Kaposi's Sarcoma

The 20-year search for an infectious agent associated with Kaposi's sarcoma (KS) may be over. Researchers at Columbia-Presbyterian Medical Center in New York have reported significant evidence directly linking a probable new herpesvirus to KS in AIDS patients.

Dr. Yuan Chang, Assistant Professor of Pathology at Columbia University College of Physicians & Surgeons, and Dr. Patrick Moore, Assistant Professor of Public Health at Columbia University School of Public Health, co-principal investigators of the research, found unique DNA sequences from what may be a new type of human herpesvirus in 93% of KS lesions from 27 deceased AIDS patients. The sequences generally were not found in the patients' non-KS tissues.

The DNA sequences found in the KS lesions are most similar to the DNA sequences of a group of herpesviruses known as gamma-herpesviruses. The new virus, which is thought to be sexually transmitted, is most closely related to the Epstein-Barr virus.

The Columbia researchers' findings open the way to potential improvements in the diagnosis and treatment of KS patients, and provide one more example, among only a handful, of a virus being implicated in cancer causation.

"Ours is the first evidence, as far as I know, of a reliable molecular marker, DNA sequences, found specifically in KS tissue," says Dr. Chang. The investigators also tested the reliability of their molecular marker by correctly predicting KS in 11 tissue samples provided to them blindly from the University of Pittsburgh.

At present, these findings do not change the standard treatment for KS. It is not yet known whether drugs that are currently effective against herpesviruses would have any effect on this presumed virus. In the future, however, a diagnostic test or therapeutic agent could be developed based on the DNA sequence, or from antibodies raised against the virus.

"If we can prove that this putative virus actually causes the cancer, diagnostic tests could be developed that might help clinicians determine sooner who may be at risk for developing Kaposi's sarcoma," says Dr. Chang.

For some time, epidemiologists have thought that a sexually transmitted agent might be responsible for the KS disease pattern seen in gay and bisexual AIDS patients. Gay and bisexual men with AIDS are 20 times more likely than hemophiliacs to develop KS (Lancet, 335:125, 1990). Women with AIDS also are more likely to develop KS if their partners are bisexual men rather than intravenous drug users.

"While we have no direct evidence that KS is sexually transmitted, the higher rates among gay and bisexual men with AIDS, compared to hemophiliacs with AIDS, suggest that it might be sexually transmitted," says Dr. Moore. "For now, it is prudent to say that safe sex practices, besides preventing the spread of HIV, probably may prevent the transmission of this presumed herpesvirus."

Dr. Moore adds that there may be multiple modes of transmission of the new virus, and there is no evidence that it can be transmitted casually. The virus was not found in tissue from 85 individuals without AIDS or KS, indicating that it is probably not common to the general population. The researchers currently are determining whether the viral DNA sequences they found are present in KS lesions of non-AIDS patients.

Infectious agents suspected of causing KS over the past 20 years include viruses, such as cytomegalovirus, hepatitis B virus, human herpesvirus 6, and HIV; and bacteria, such as Mycoplasma penetrans. Even noninfectious agents, such as nitrite inhalers, or poppers, a drug used by the gay community, were thought to be a cofactor for KS. "Extensive research has not demonstrated a causal relationship between these agents and KS in AIDS," write the scientists.

Drs. Chang and Moore used the latest tools in molecular biology analysis-representational difference analysis and the polymerase chain reaction-to isolate the extraneous viral DNA sequences. They have identified portions of three separate genes that appear to belong to this new virus. The sequences also have been found in lymphoma tissue and lymph nodes from 3 of 39 other AIDS patients. The role of the sequences in AIDS-associated lymphomas is being investigated.

Although the scientists believe that they have strong evidence implicating the virus as the causative agent of KS in AIDS patients, they need to do additional work to prove it. "Although this virus is not found in most non-KS tissue, it is still possible that this agent is a common latent virus in humans that preferentially colonizes KS lesions in immunocompromised patients," the authors say.

If this presumed herpesvirus is shown to cause KS, it would be another addition to the list of viruses known to cause cancer. These include papillomavirus (cervical cancer), hepatitis B (liver cancer), and Epstein-Barr virus (Burkitt's lymphoma and nasopharyngeal carcinoma).

Drs. Chang and Moore, a wife and husband team, took a year to identify the sequences with their collaborators. The other investigators on the project were Drs. Ethel Cesarman and Daniel Knowles, formerly of Columbia-Presbyterian Medical Center but now with Cornell Medical Center in New York City; Dr. Melissa Pessin, a postdoctoral fellow in Columbia's Department of Pathology; and Drs. Frank Lee and Janice Culpepper of DNAX Research Institute in Palo Alto, California.

This research was funded by start-up funds from Columbia's Department of Pathology and the School of Public Health. The full report is published in Science, Vol 266:1803-1804.

 
Loading comments...
Please Wait 20 seconds or click here to close